Dose volume histogram analysis of normal structures associated with accelerated partial breast irradiation delivered by high dose rate brachytherapy and comparison with whole breast external beam radiotherapy fields
-
Published:2008-11-19
Issue:1
Volume:3
Page:
-
ISSN:1748-717X
-
Container-title:Radiation Oncology
-
language:en
-
Short-container-title:Radiat Oncol
Author:
Stewart Alexandra J,O'Farrell Desmond A,Cormack Robert A,Hansen Jorgen L,Khan Atif J,Mutyala Subhakar,Devlin Phillip M
Abstract
Abstract
Purpose
To assess the radiation dose delivered to the heart and ipsilateral lung during accelerated partial breast brachytherapy using a MammoSite™ applicator and compare to those produced by whole breast external beam radiotherapy (WBRT).
Materials and methods
Dosimetric analysis was conducted on patients receiving MammoSite breast brachytherapy following conservative surgery for invasive ductal carcinoma. Cardiac dose was evaluated for patients with left breast tumors with a CT scan encompassing the entire heart. Lung dose was evaluated for patients in whom the entire lung was scanned. The prescription dose of 3400 cGy was 1 cm from the balloon surface. MammoSite dosimetry was compared to simulated WBRT fields with and without radiobiological correction for the effects of dose and fractionation. Dose parameters such as the volume of the structure receiving 10 Gy or more (V10) and the dose received by 20 cc of the structure (D20), were calculated as well as the maximum and mean doses received.
Results
Fifteen patients were studied, five had complete lung data and six had left-sided tumors with complete cardiac data. Ipsilateral lung volumes ranged from 925–1380 cc. Cardiac volumes ranged from 337–551 cc. MammoSite resulted in a significantly lower percentage lung V30 and lung and cardiac V20 than the WBRT fields, with and without radiobiological correction.
Conclusion
This study gives low values for incidental radiation received by the heart and ipsilateral lung using the MammoSite applicator. The volume of heart and lung irradiated to clinically significant levels was significantly lower with the MammoSite applicator than using simulated WBRT fields of the same CT data sets.
Trial registration
Dana Farber Trial Registry number 03-179
Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging,Oncology
Reference40 articles.
1. Sanders ME, Scroggins T, Ampil FL, Li BD: Accelerated partial breast irradiation in early-stage breast cancer. J Clin Oncol 2007,25(8):996-1002. 10.1200/JCO.2006.09.7436 2. Vicini FA, Beitsch PD, Quiet CA, Keleher A, Garcia D, Snider HC, Gittleman MA, Zannis VJ, Kuerer H, Whitacre EB, Whitworth PW, Fine RE, Haffty BG, Stolier A, Arrambide LS: First analysis of patient demographics, technical reproducibility, cosmesis, and early toxicity: results of the American Society of Breast Surgeons MammoSite breast brachytherapy trial. Cancer 2005,104(6):1138-48. 10.1002/cncr.21289 3. Arthur DW, Koo D, Zwicker RD, Tong S, Bear HD, Kaplan BJ, Kavanagh BD, Warwicke LA, Holdford D, Amir C, Archer KJ, Schmidt-Ullrich RK: Partial breast brachytherapy after lumpectomy: Low-dose-rate and high-dose-rate experience. Int J Radiat Oncol Biol Phys 2003,56(3):681-9. 4. Baglan KL, Martinez AA, Frazier RC, Kini VR, Kestin LL, Chen PY, Edmundson G, Mele E, Jaffray D, Vicini FA: The use of high-dose-rate brachytherapy alone after lumpectomy in patients with early-stage breast cancer treated with breast-conserving surgery. Int J Radiat Oncol Biol Phys 2001,50(4):1003-11. 10.1016/S0360-3016(01)01547-4 5. Benitez PR, Streeter O, Vicini F, Mehta V, Quiet C, Kuske R, Hayes MK, Arthur D, Kuerer H, Freedman G, Keisch M, Dipetrillo T, Khan D, Hudes R: Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study. Am J Surg 2006,192(4):427-33. 10.1016/j.amjsurg.2006.06.013
Cited by
38 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|